Literature DB >> 18775683

Receptor for advanced glycation end products and neuronal deficit in the fatal brain edema of diabetic ketoacidosis.

William H Hoffman1, Carol M Artlett, Weixian Zhang, Christian W Kreipke, Gregory G Passmore, Jose A Rafols, Anders A F Sima.   

Abstract

Radiologic and neuropsychologic studies suggest that diabetes mellitus causes structural changes in the brain and adversely effects cognitive development. Experimental animal models of type 1 diabetes mellitus (T1DM) have advanced these findings by demonstrating duration-related neuronal and cognitive deficits in T1DM BB/Wor rats. We studied the expression of receptor for advanced glycation end products (RAGE) and neuronal densities in the brains of two patients who died as the result of clinical brain edema(BE)that developed during the treatment of severe diabetic ketoacidosis (DKA). RAGE was markedly and diffusely expressed in blood vessels, neurons, and the choroid plexus and co-localized with glial fibrillary acidic protein (GFAP) in astrocytes. Significant neuronal loss was seen in the hippocampus and frontal cortex. Astrocytosis was present and white matter was atrophied in both cases when compared to age-matched controls. Our data supports that a neuroinflammatory response occurs in the BE associated with DKA, and that even after a relatively short duration of poorly controlled T1DM, the pathogenesis of primary diabetic encephalopathy can be initiated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18775683     DOI: 10.1016/j.brainres.2008.08.041

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

Review 1.  Autophagy in the brains of young patients with poorly controlled T1DM and fatal diabetic ketoacidosis.

Authors:  William H Hoffman; John J Shacka; Anuska V Andjelkovic
Journal:  Exp Mol Pathol       Date:  2011-11-06       Impact factor: 3.362

2.  Ghrelin inhibits high glucose-induced PC12 cell apoptosis by regulating TLR4/NF-κB pathway.

Authors:  Xiaoyan Liu; Qian Xiao; Kexiang Zhao; Yuan Gao
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

3.  Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis.

Authors:  William H Hoffman; Sandra L Siedlak; Yang Wang; Rudy J Castellani; Mark A Smith
Journal:  Brain Res       Date:  2010-10-30       Impact factor: 3.252

4.  Presenting predictors and temporal trends of treatment-related outcomes in diabetic ketoacidosis.

Authors:  Christopher M Horvat; Heba M Ismail; Alicia K Au; Luigi Garibaldi; Nalyn Siripong; Sajel Kantawala; Rajesh K Aneja; Diane S Hupp; Patrick M Kochanek; Robert Sb Clark
Journal:  Pediatr Diabetes       Date:  2018-04-26       Impact factor: 4.866

5.  Intracerebral matrix metalloproteinase 9 in fatal diabetic ketoacidosis.

Authors:  William H Hoffman; Cornelia D Cudrici; Dallas Boodhoo; Alexandru Tatomir; Violeta Rus; Horea Rus
Journal:  Exp Mol Pathol       Date:  2019-04-13       Impact factor: 3.362

Review 6.  Targeting choroid plexus epithelium as a novel therapeutic strategy for hydrocephalus.

Authors:  Yijian Yang; Jian He; Yuchang Wang; Chuansen Wang; Changwu Tan; Junbo Liao; Lei Tong; Gelei Xiao
Journal:  J Neuroinflammation       Date:  2022-06-17       Impact factor: 9.587

7.  Immunohistochemical analysis of transporters related to clearance of amyloid-β peptides through blood-cerebrospinal fluid barrier in human brain.

Authors:  Koichi Matsumoto; Yoichi Chiba; Ryuji Fujihara; Hiroyuki Kubo; Haruhiko Sakamoto; Masaki Ueno
Journal:  Histochem Cell Biol       Date:  2015-10-08       Impact factor: 4.304

8.  Inflammation in Diabetic Encephalopathy is Prevented by C-Peptide.

Authors:  Anders A F Sima; Weixian Zhang; Christian W Kreipke; José A Rafols; William H Hoffman
Journal:  Rev Diabet Stud       Date:  2009-05-10

9.  Sequential abnormalities in type 1 diabetic encephalopathy and the effects of C-Peptide.

Authors:  Anders A F Sima; Weixian Zhang; Otto Muzik; Christian W Kreipke; José A Rafols; William H Hoffman
Journal:  Rev Diabet Stud       Date:  2009-11-10

10.  Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent.

Authors:  Crissey L Pascale; Miles C Miller; Catherine Chiu; Matthew Boylan; Ilias N Caralopoulos; Liliana Gonzalez; Conrad E Johanson; Gerald D Silverberg
Journal:  Fluids Barriers CNS       Date:  2011-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.